Statement of the Spanish interdisciplinary vascular prevention committee on the updated European guidelines on cardiovascular disease prevention 2021 Comentario del CEIPV a las nuevas guías europeas de prevención cardiovascular 2021
Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau)
Camafort, Miguel (Sociedad Española de Medicina Interna)
Castellanos, María del Mar (Sociedad Española de Neurología)
Clará Velasco, Alberto (Sociedad Española de Angiología y Cirugía Vascular)
Cortés, Olga (Asociación Española de Pediatría de Atención Primaria)
Díaz Rodríguez, Ángel (Sociedad Española de Médicos de Atención Primaria (SEMERGEN))
Elosua, Roberto (Sociedad Española de Epidemiología)
Gorostidi, Manuel (Sociedad Española de Nefrología)
Hernández, Antonio M. (Sociedad Española de Diabetes)
Herranz, María (Federación de Asociaciones de Enfermería Comunitaria y Atención Primaria (FAECAP))
Justo, Soledad (Ministerio de Sanidad)
Lahoz, Carlos (Sociedad Española de Medicina Interna)
Niño, Pilar (Sociedad Española de Medicina y Seguridad del Trabajo)
Pallarés-Carratalá, Vicente (Sociedad Española de Médicos de Atención Primaria (SEMERGEN))
Pedro-Botet, Juan (Sociedad Española de Arteriosclerosis)
Pérez Pérez, Antonio (Institut d'Investigació Biomèdica Sant Pau)
Royo-Bordonada, Miguel Ángel (Instituto de Salud Carlos III)
Santamaría, Rafael (Sociedad Española de Nefrología)
Tresserras, Ricard (Sociedad Española de Salud Pública y Administración Sanitaria (SESPAS))
Zamora, Alberto (Sociedad Española de Arteriosclerosis)
Zuza, Inés (Ministerio de Sanidad)
Armario, Pedro (Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial.)

Date:	2022
Abstract:	We present the Spanish adaptation of the 2021 European Guidelines on Cardiovascular Disease (CVD) prevention in clinical practice. The current guidelines besides the individual approach greatly emphasize on the importance of population level approaches to the prevention of cardiovascular diseases. Systematic global CVD risk assessment is recommended in individuals with any major vascular risk factor. Regarding LDL-Cholesterol, blood pressure, and glycemic control in patients with diabetes mellitus, goals and targets remain as recommended in previous guidelines. However, it is proposed a new, stepwise approach (Step 1 and 2) to treatment intensification as a tool to help physicians and patients pursue these targets in a way that fits patient profile. After Step 1, considering proceeding to the intensified goals of Step 2 is mandatory, and this intensification will be based on 10-year CVD risk, lifetime CVD risk and treatment benefit, comorbidities and patient preferences. The updated SCORE algorithm (SCORE2 and SCORE-OP) is recommended in these guidelines, which estimates an individual's 10-year risk of fatal and non-fatal CVD events (myocardial infarction, stroke) in healthy men and women aged 40-89 years. Another new and important recommendation is the use of different categories of risk according different age groups (< 50, 50-69, ≥ 70 years). Different flow charts of CVD risk and risk factor treatment in apparently healthy persons, in patients with established atherosclerotic CVD, and in diabetic patients are recommended. Patients with chronic kidney disease are considered high risk or very high-risk patients according to the levels of glomerular filtration rate and albumin-to-creatinine ratio. New lifestyle recommendations adapted to the ones published by the Spanish Ministry of Health as well as recommendations focused on the management of lipids, blood pressure, diabetes and chronic renal failure are included.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra, i la creació d'obres derivades, sempre que no sigui amb finalitats comercials i que es distribueixin sota la mateixa llicència que regula l'obra original. Cal que es reconegui l'autoria de l'obra original.
Language:	Castellà
Document:	Article ; recerca ; Versió publicada
Subject:	Prevention and control ; Vascular diseases ; Clinical practice guidelines ; Healthy diet ; Arterial hypertension ; Diabetes ; Lipid control ; Smoking ; Cardiovascular risk
Published in:	Angiologia, Vol. 74 Núm. 5 (septiembre 2022) , p. 237-248, ISSN 1695-2987

DOI: 10.20960/angiologia.00411

12 p, 2.6 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles